Literature DB >> 15855877

Association of G-protein beta-3 subunit gene (GNB3) T825 allele with Type II diabetes.

Jawad G Kiani, Mohammad Saeed, S Hassan Parvez, Philippe M Frossard.   

Abstract

To date, the human G-protein beta 3 subunit (GNB3) gene and some of its variants represent some of the best examples of genetic influences that are involved in the determination of hypertension and obesity, which make it a sensible candidate gene for type 2 diabetes. To assess the influence of GNB3 in type II diabetes mellitus (NIDDM), we carried out a retrospective, case-control study of variant GNB3 825C>T for putative correlations with NIDDM amongst nationals from the United Arab Emirates (Emirati) - an ethnic group characterized by no alcohol intake and no cigarette smoking. We investigated a sample population of 510 Emirati (257 men, 253 women) comprising two groups - 254 controls and 256 patients with clinical diagnoses of type 2 diabetes (cases). The GNB3 C825T dimorphism showed an association with NIDDM Chi2 =22.5, 2 df, P<0.001). Further analysis revealed that the GNB3 T/T 825 genotype was positively associated with NIDDM (Yates corrected Chi2=20.6, 2 df, P<0.001; odds ratio of 2.44 with a 95% confidence interval of 1.64 - 3.63) compared to pooled CC/CT genotypes. Our data shows that GNB3 T825 allele may be involved in the pathogenesis of DM through a pathway that is different from the one implicated in obesity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15855877

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  9 in total

1.  Delivering a pharmacogenetic service: is there a role for genetic counselors?

Authors:  Alice Callard; William Newman; Katherine Payne
Journal:  J Genet Couns       Date:  2011-11-04       Impact factor: 2.537

Review 2.  Pharmacogenomics of beta-adrenergic receptors and their accessory signaling proteins in heart failure.

Authors:  Gerald W Dorn; Stephen B Liggett
Journal:  Clin Transl Sci       Date:  2008-12       Impact factor: 4.689

Review 3.  G-Protein β3-Subunit Gene C825T Polymorphism and Cardiovascular Risk: An Updated Review.

Authors:  Andrea Semplicini; Tommaso Grandi; Chiara Sandonà; Arianna Cattelan; Giulio Ceolotto
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-04-23

4.  Studies of the association of the GNB3 825C>T polymorphism with components of the metabolic syndrome in white Danes.

Authors:  G Andersen; J Overgaard; A Albrechtsen; C Glümer; K Borch-Johnsen; T Jørgensen; T Hansen; O Pedersen
Journal:  Diabetologia       Date:  2005-11-12       Impact factor: 10.122

Review 5.  Pharmacogenetics of glucose-lowering drug treatment: a systematic review.

Authors:  Ozlem Bozkurt; Anthonius de Boer; Diederick E Grobbee; Eibert R Heerdink; Huib Burger; Olaf H Klungel
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

6.  The -308G/A of Tumor Necrosis Factor (TNF)-α and 825C/T of Guanidine Nucleotide Binding Protein 3 (GNB3) are associated with the onset of acute myocardial infarction and obesity in Taiwan.

Authors:  Wei-To Chang; Yi-Cheng Wang; Chun-Chang Chen; Shi-Kun Zhang; Chen-Hsun Liu; Fu-Hsin Chang; Li-Sung Hsu
Journal:  Int J Mol Sci       Date:  2012-02-09       Impact factor: 6.208

Review 7.  Role of GNB3, NET, KCNJ11, TCF7L2 and GRL genes single nucleotide polymorphism in the risk prediction of type 2 diabetes mellitus.

Authors:  Saliha Rizvi; Syed Tasleem Raza; Qamar Rahman; Farzana Mahdi
Journal:  3 Biotech       Date:  2016-12-02       Impact factor: 2.406

8.  Genetic associations with diabetes: meta-analyses of 10 candidate polymorphisms.

Authors:  Linlin Tang; Lingyan Wang; Qi Liao; Qinwen Wang; Leiting Xu; Shizhong Bu; Yi Huang; Cheng Zhang; Huadan Ye; Xuting Xu; Qiong Liu; Meng Ye; Yifeng Mai; Shiwei Duan
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

9.  Effects of interacting networks of cardiovascular risk genes on the risk of type 2 diabetes mellitus (the CODAM study).

Authors:  Marleen M J van Greevenbroek; Jian Zhang; Carla J H van der Kallen; Paul M H Schiffers; Edith J M Feskens; Tjerk W A de Bruin
Journal:  BMC Med Genet       Date:  2008-04-24       Impact factor: 2.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.